Aclaris Therapeutics, Inc. (ACRS)
Total Valuation
ACRS has a market cap or net worth of $74.38 million. The enterprise value is -$28.36 million.
| Market Cap | 74.38M |
| Enterprise Value | -28.36M |
Important Dates
The next estimated earnings date is Thursday, February 22, 2024, before market open.
| Earnings Date | Feb 22, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ACRS has 70.84 million shares outstanding. The number of shares has increased by 6.20% in one year.
| Shares Outstanding | 70.84M |
| Shares Change (YoY) | +6.20% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 2.60% |
| Owned by Institutions (%) | 98.16% |
| Float | 41.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.47 |
| Forward PS | 5.61 |
| PB Ratio | 0.48 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.51, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.51 |
| Quick Ratio | 3.78 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -64.50% and return on invested capital (ROIC) is -73.98%.
| Return on Equity (ROE) | -64.50% |
| Return on Assets (ROA) | -48.90% |
| Return on Capital (ROIC) | -73.98% |
| Revenue Per Employee | $214,320 |
| Profits Per Employee | -$1.15M |
| Employee Count | 100 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.49% in the last 52 weeks. The beta is 0.27, so ACRS's price volatility has been lower than the market average.
| Beta (1Y) | 0.27 |
| 52-Week Price Change | -93.49% |
| 50-Day Moving Average | 2.33 |
| 200-Day Moving Average | 6.94 |
| Relative Strength Index (RSI) | 34.25 |
| Average Volume (30 Days) | 4,541,654 |
Short Selling Information
The latest short interest is 5.91 million, so 8.35% of the outstanding shares have been sold short.
| Short Interest | 5.91M |
| Short Previous Month | 4.76M |
| Short % of Shares Out | 8.35% |
| Short % of Float | 14.23% |
| Short Ratio (days to cover) | 1.06 |
Income Statement
In the last 12 months, ACRS had revenue of $21.43 million and -$114.63 million in losses. Loss per share was -$1.66.
| Revenue | 21.43M |
| Gross Profit | 8.27M |
| Operating Income | -115.89M |
| Pretax Income | -114.63M |
| Net Income | -114.63M |
| EBITDA | -113.80M |
| EBIT | -114.63M |
| Loss Per Share | -$1.66 |
Balance Sheet
The company has $103.05 million in cash and $310,000 in debt, giving a net cash position of $102.74 million or $1.45 per share.
| Cash & Cash Equivalents | 103.05M |
| Total Debt | 310,000 |
| Net Cash | 102.74M |
| Net Cash Per Share | $1.45 |
| Equity / Book Value | 156.33M |
| Book Value Per Share | 2.21 |
| Working Capital | 95.75M |
Cash Flow
In the last 12 months, operating cash flow was -$90.68 million and capital expenditures -$973,000, giving a free cash flow of -$91.65 million.
| Operating Cash Flow | -90.68M |
| Capital Expenditures | -973,000 |
| Free Cash Flow | -91.65M |
| FCF Per Share | -$1.29 |
Margins
Gross margin is 38.56%, with operating and profit margins of -540.73% and -534.83%.
| Gross Margin | 38.56% |
| Operating Margin | -540.73% |
| Pretax Margin | -534.83% |
| Profit Margin | -534.83% |
| EBITDA Margin | -530.98% |
| EBIT Margin | -534.83% |
| FCF Margin | -427.64% |
Dividends & Yields
ACRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -154.11% |
| FCF Yield | -123.22% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.20% |
| Shareholder Yield | -6.20% |
Analyst Forecast
The average price target for ACRS is $16.40, which is 1,461.91% higher than the current price. The consensus rating is "Buy".
| Price Target | $16.40 |
| Price Target Difference | 1,461.91% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 11.05% |
| EPS Growth Forecast (5Y) | 1.71% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACRS has an Altman Z-Score of -5.32 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.32 |
| Piotroski F-Score | 1 |